Patents by Inventor Benjamin Thompson

Benjamin Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds
    Patent number: 8222261
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: January 13, 2009
    Date of Patent: July 17, 2012
    Assignee: GlaxoSmithKline, LLC
    Inventors: Subba R Katamreddy, Richard Dama Caldwell, Dennis Heyer, Vincente Samano, James Benjamin Thompson, Andrew J Carpenter, Christopher R Conlee, Eric Eugene Boros, Brian D Thompson
  • SYSTEM AND METHOD FOR DETERMINING AFFINITY GROUPS AND CO-LOCATING THE AFFINITY GROUPS IN A DISTRIBUTING NETWORK
    Publication number: 20110060821
    Abstract: In at least one embodiment, an apparatus for determining one or more affinity groups in a distributed network is provided. A first distributed computing device is operably coupled to a plurality of clients for enabling electronic interactive activities therebetween. The first distributed computing device is configured to detect at least one network interaction among the plurality of clients. The first distributed computing device is further configured to generate at least one weighted value based on the number of detected network interactions. The first distributed computing device is further configured to establish an affinity group comprising at least one client from the plurality of clients based on the at least one weighted value.
    Type: Application
    Filed: September 10, 2009
    Publication date: March 10, 2011
    Applicant: SUN MICROSYSTEMS, INC.
    Inventors: Jane Alice Loizeaux, James H. Waldo, Keith Benjamin Thompson
  • CCR5 antagonists as therapeutic agents
    Patent number: 7645771
    Abstract: The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: January 12, 2010
    Assignee: SmithKline Beecham Corp.
    Inventors: Wieslaw Mieczyslaw Kazmierski, Chrisopher Joseph Aquino, Neil Bifulco, Eric Eugene Boros, Brian Andrew Chauder, Pek Yoke Chong, Maosheng Duan, Felix Deanda, Jr., Cecilia Suarez Koble, Ed Williams McLean, Jennifer Poole Peckham, Angilique C Perkins, James Benjamin Thompson, Dana Vanderwall
  • SYSTEM AND METHOD FOR GROUP TO GROUP ENTERTAINMENT
    Publication number: 20070156883
    Abstract: A hardware and software platform for collaboratively reviewing prior group to group interactions while planning, producing and archiving new group to group interactions. The platform may be used to collaboratively create group to group interactions. The system may be used to link two or more stadia, movie theatres or homes so as to provide interaction between the groups at each location simultaneously as a game or other event takes place.
    Type: Application
    Filed: January 2, 2007
    Publication date: July 5, 2007
    Applicant: VISUAL EXCHANGE NETWORK, LLC
    Inventors: Benjamin Thompson, Ella Thompson